Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oculex Pharmaceuticals Inc.

Division of Allergan PLC

Latest From Oculex Pharmaceuticals Inc.

Spotting Switching Opportunities in Ophthalmology

The buzz around ophthalmology is trickling down to company creation. French start-up Fovea will buy in and build compounds tackling the root causes of retinal diseases.
BioPharmaceutical Business Strategies

Drug Development's Preclinical Bottleneck

Thanks to genomics, combinatorial chemistry, and high-throughput screening, pharmaceutical companies have more drug leads than ever. But which are the drugs? Start-up firms with faster, smarter approaches to preclinical testing may help sort out the answers. Information technology will play a key role in lead optimization as new firms with simulation software are helping drug developers plot development strategies earlier than ever.
BioPharmaceutical Research and Development Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Donald J Eaton, Chmn. & CEO
    Veron Wong, MD, CSO
  • Contact Info
  • Oculex Pharmaceuticals Inc.
    Phone: (408) 481-0424
    639 N. Pastoria Ave.
    Sunnyvale, CA 94086